Clinical Trial

Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

Name: Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections — clinical trial record (NCT06363370)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of interferon α1b (GB05) in the treatment of children under 2 years of age with respiratory syncytial virus infection.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-04-10.

Trial Details

NCT Number	NCT06363370
Lead Sponsor	Kexing Biopharm Co., Ltd.
Conditions	Respiratory Syncytial Virus Infections
Enrollment	322 participants
Start Date	2024-03-27
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-01